India's Central Drugs Standard Control Organization (CDSCO) has issued a document to address the frequent questions that the medtech industry has raised in response to the Medical Device Rules that came into effect in January.
The FAQ document clarifies a variety of issues, including inspection timelines, how to apply for and renew manufacturing licenses, the submission of clinical data for devices already on the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?